Moreover, we found that pharmacological or molecular inhibition of HDAC6 reduced PAH-PASMC migration, as assessed by scratch wound assay in vitro (Supplementary Figure S5). The gene discussed is HDAC6; the disease is pulmonary arterial hypertension.